RedHill Biopharma Ltd (RDHL) is traded on Nasdaq Capital Markets in USA. It is located in ISRAEL and employs 12 people. RedHill Biopharma is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 142.69 M. RedHill Biopharma Ltd has 171.64 M outstanding shares of which 213.71 K shares are at this time shorted by private and institutional investors with about 2.45 trading days to cover.
Redhill Biopharma currently holds about 51.07 M in cash with (37.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.97.
Check RedHill Biopharma Probability Of Bankruptcy